Acura Pharmaceuticals Inc (ACUR) Return on Investment ROI from the fourth quarter of 2021 to fourth quarter of 2020 and for the year 2021, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Acura Pharmaceuticals inc  (NASDAQ: ACUR)


Acura Pharmaceuticals Inc's ROI from its fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Acura Pharmaceuticals Inc's ROI in the fourth quarter of 2021?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Acura Pharmaceuticals Inc's return on investment (ROI) in its fourth quarter of 2021

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 0 1 -6 -6
Return On Investment (TTM) 83.54 % 44.53 % 64.27 % - -
ACUR's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -1 -1 -2 -1 -1

ACUR Company Profile >> Back to ACUR Roi Comparisons >> See Annual ACUR Return On Investment



Return On Investment ACUR's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Acura Pharmaceuticals Inc's IV. Quarter Investments $ 0 Millions ACUR's Balance sheet
Acura Pharmaceuticals Inc's IV. Quarter Income $ 0 Millions Quarterly ACUR's Income Statement
ACUR's Income by Division See ACUR's Income by Division


ACUR Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 0 -6 1 1 0
Y / Y Investment Growth - - 107.53 % - -
Net Income in Millions -1 -1 -4 -4 -6
Y / Y Net Income Growth - - - - -
Annual Return On Investment -254.78 % - -253.63 % -535.84 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ACUR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ACUR's Competitors
Subscribers only: Roi for Acura Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ACUR's Customers

Other Ratios
ACUR's Roa ACUR's Inventory Turnover Ratio ACUR's Growth Rates ACUR's Dividend Statistics
ACUR's Profitability Ratios ACUR's Asset Turnover Ratio ACUR's Dividend Growth
ACUR's Roe ACUR's Valuation Ratios ACUR's Financial Strength Ratios ACUR's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI
Notable Labs Ltd   188.79 %
Entrada Therapeutics Inc   154.28 %
Moderna Inc   128.20 %
Chp Merger Corp   119.41 %
Altamira Therapeutics Ltd   118.29 %
Omeros Corporation  117.05 %
Galmed Pharmaceuticals Ltd   105.45 %
Sinovac Biotech Ltd  93.85 %
Vyne Therapeutics Inc   93.73 %
Agios Pharmaceuticals Inc   90.82 %
Biontech Se  84.02 %
Vivos Therapeutics Inc   72.72 %
Ovid Therapeutics Inc   59.58 %
Carisma Therapeutics Inc   58.59 %
Glucotrack Inc   58.06 %
Biomx Inc  57.30 %
Ironwood Pharmaceuticals inc   55.38 %
Iteos Therapeutics Inc   54.32 %
Reflect Scientific Inc  52.07 %
Fulgent Genetics Inc   50.82 %
Silo Pharma Inc  50.34 %
Siga Technologies Inc  49.80 %
Uniqure N v   49.63 %
Vir Biotechnology Inc   49.45 %
Molecular Templates Inc   48.02 %
Biocept Inc   47.39 %
Integrated Biopharma Inc  46.85 %
Retractable Technologies Inc  46.68 %
Regeneron Pharmaceuticals Inc   43.91 %
Biodelivery Sciences International Inc   42.72 %

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.